comparemela.com

Page 16 - Xide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cabral Gold Inc : Cabral Gold Drills 13 0m @ 4 6 g/t Gold Including 1 0m @ 49 2 g/t Gold within Gold-in-Oxide Blanket at the PDM Target, Cuiú Cuiú District

Vancouver, British Columbia (Newsfile Corp. - July 21, 2022) - Cabral Gold Inc. (TSXV: CBR) (OTC PINK: CBGZF) ("Cabral" or the "Company") is pleased to provide assay results from nine additional RC holes

United kingdomBritish columbiaAlan carterGuillermo hughesNational instrumentCabral gold incCompanya common shareBritish columbia newsfile corpVenture exchangeRegulation services providerGold districtPau de merendaCentral trendCentral northPrivate placementEach warrant

Torq Resources Inc : Torq Initiates Follow-up Drill Program to Discovery at Margarita Iron-Oxide-Copper-Gold Project

VANCOUVER, BC / ACCESSWIRE / July 14, 2022 / Torq Resources Inc. (TSX-V:TORQ, OTCQX:TRBMF) ("Torq" or the "Company") is pleased to announce that it has commenced its follow-up drill program at the Margarita

British columbiaNatasha frakesShawn wallaceMichael henrichsenCorporate communicationsTorq resources incVenture exchangeLab in copiapoRegulation services providerPhase ii drill programTorq resourcesMargarita iron oxide copper goldCoasta coardilleraChief geological officerResources incCoastal cordillera

SaNOtize Research & Development Corp : Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days

Phase 3 trial demonstrated a reduction in SARS-CoV-2 viral load in high-risk COVID-19 patients by 94% and 99% within 24 and 48 hours of treatment, respectively Median time to a negative PCR

Hong kongUnited kingdomBritish columbiaChris millerKostenloser wertpapierhandelSean gjosGilly regevSanotize coThelancet regional health southeast asiaSanotize research development corpEuropean unionIndia central drugs standard control organizationGlenmark pharmaceuticals limitedBusiness developmentResearch development corpProgression scale

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development

Hong kongBritish columbiaRepublic ofEast timorSri lankaMonika tandonGilly regevSanotize coPrnewswire glenmark pharmaceuticals limitedLancet regional health southeast asiaStrategic partnershipSanotize researchDevelopment corpGlenmark pharmaceuticals ltdClinical developmentPharmaceuticals limited

ASM INTERNATIONAL N V LAUNCHES TENZATM ALD FOR SILICON OXIDE GAP-FILL AND LINERS

Almere, The NetherlandsJuly 13, 2022, 5.45 p.m. CET New process technology addresses 300mm advanced memory and logic/foundry applications with best film qu

United statesSan franciscoHichem msaadInternationalnv euronext amsterdamEuronext amsterdam stock exchangeEuronext amsterdamHichemm saadChief technology officerNote regarding forward looking statements

vimarsana © 2020. All Rights Reserved.